Tumor-Specific Programs

The UCT Frankfurt-Marburg has established Tumor-Specific Programs in which surgical oncologists, medical oncologists and diagnosticians focus on a specific cancer type in order to advance and better patient care in that area of expertise. Our expert cancer teams take over the coordination of interdisciplinary patient treatment as well as all related scientific and clinical research activities involved in running clinical trials across all three UCT Frankfurt-Marburg sites.

Every week, these expert cancer teams meet in 36 tumor boards that are dedicated to developing the best treatment paths for our cancer patients. Working together with our regional partners, they also agree on guidelines for diagnosis and treatment and take an active role in quality management by approving and installing optimized work processes. They initiate inter-regional partnerships and coordinate the integration of patient organizations and support groups into the work of the UCT. The Tumor-Specific Programs also play an important role in the area of research: they appoint Scientific Board members, evaluate participation in clinical trials and initiate research projects. The coordinators of each Tumor-Specific Program are in constant contact with each other and are responsible for coordinating activities between the various sites and other Tumor-Specific Programs.

Contacts at the Tumor-Specific Programs

Dermatologic Oncology

  • Coordinator at University Hospital Frankfurt: Dr. Johannes Kleemann
  • Coordinator at University Hospital Marburg: Dr. Armin Bender

Gastrointestinal Oncology

  • Coordinator at University Hospital Frankfurt: Prof. Dr. Jörg Trojan
  • Coordinator at Nordwest Hospital: Prof. Dr. Salah-Eddin Al-Batran
  • Coordinator at University Hospital Marburg: Prof. Dr. Thomas Gress

Gynecologic Oncology

  • Coordinator at University Hospital Frankfurt: Prof. Dr. Sven Becker
  • Coordinator at Nordwest Hospital: Prof. Dr. Jörg Engel
  • Coordinator at University Hospital Marburg: Prof. Dr. Uwe Wagner

Hematologic Neoplasms

  • Coordinator at University Hospital Frankfurt: Dr. Björn Steffen
  • Coordinator at Nordwest Hospital: Prof. Dr. Elke Jäger
  • Coordinator at University Hospital Marburg: Prof. Dr. Andreas Neubauer

Head and Neck Tumors

  • Coordinator at University Hospital Frankfurt: Dr. Sven Balster
  • Coordinator at University Hospital Marburg: Prof. Dr. Boris Stuck

Neuro-oncology

  • Coordinator at University Hospital Frankfurt: Prof. Dr. Joachim Steinbach
  • Coordinator at University Hospital Marburg: Prof. Dr. Christopher Nimsky

Pediatric Oncology

  • Coordinator at University Hospital Frankfurt: Prof. Dr. Thomas Klingebiel

Sarcomas

  • Coordinator at University Hospital Frankfurt: Dr. Marit Ahrens
  • Coordinator at Nordwest Hospital: Dr. Dragan Kiselicki
  • Coordinator at University Hospital Marburg: Dr. Jörg Hoffmann

Thoracic Oncology

  • Coordinator at University Hospital Frankfurt: Prof. Dr. Gernot Rohde
  • Coordinator at Nordwest Hospital: PD Dr. Akin Atmaca
  • Coordinator at University Hospital Marburg: Dr. Angelique Holland

Urogenital Cancers

  • Coordinator at University Hospital Frankfurt: Prof. Dr. Felix Chun
  • Coordinator at Nordwest Hospital: Prof. Dr. Eduard Becht
  • Coordinator at University Hospital Marburg: Prof. Dr. Dr. Johannes Huber